MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS)
$32 -0.12 (-0.3736%)
Analysed MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS) News Sources
Bio-Techne (TECH) Agrees To $11.5 Billion Merck KGaA Buyout
26-06-2026
yahoo.com
Merck KGaA (MKKGY) Soars 5.3%: Is Further Upside Left in the Stock?
26-06-2026
yahoo.com
Company News for Jun 26, 2026
26-06-2026
yahoo.com
Merck KGaA to acquire Bio-Techne in $11.3 billion deal
26-06-2026
qz.com
The $11 Billion Reason TECH Stock Is Up Today
26-06-2026
barchart.com
Cyllene Therapeutics Raises €33 Million Series C
07-07-2026
yahoo.com
Are Investors Undervaluing Merck KGaA (MKKGY) Right Now?
07-07-2026
yahoo.com
Merck KGaA-backed Cyllene Therapeutics secures €33m for gene therapy pipeline
07-07-2026
pharmaceutical-technology.com
Perspective Therapeutics Appoints Paul Lyne, Ph.D., as Chief Science Officer; Co-Founder Michael K. Schultz, Ph.D., Transitions to Senior Scientific Advisor
08-07-2026
yahoo.com
EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations
08-07-2026
yahoo.com
What is the current price of MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS)?
The current price of MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS) is $32.
MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS) since the previous trading day is $-0.12.
MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS) since the previous trading day is -0.3736%.
What is the most recent average sentiment score for MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS)?
The most recent average sentiment score for MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS) is 72 out of 100.
What is the most recent average sentiment for MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS)?
The most recent sentiment for MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS) is .
SEC-8K** Filing Available For MERCK KGAA-SPONSORED ADR (MKKGY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.